Despite major interest in sodium iron (III) ethylenediaminetetraacetic acid's (EDTA) potential use in food fortification programs in potentially curbing the global problem of iron deficiency and its anemia, synthesis methods of stable isotope-labeled sodium iron (III) EDTA for use in human bioavailability studies are incomplete, incorrect or totally lacking. Owing to a number of clinical research groups requiring this compound in bioavailability studies, in both developing and already developed countries, we simplified and optimized the synthesis of sodium iron (III) EDTA from a block of isotopically enriched iron metal, in order that it be easily reproduced, cheaply, using simple basic laboratory apparatus. The resulting product is of high purity (499.0%), and may be used for human stable isotope bioavailability studies. The simplicity of this method allows for the many research groups, currently doing such studies, to perform their own syntheses. Additionally, more uniformity in this synthesis will reduce the variation observed between such studies.
Iron deficiency and its anemia lowers the response of the immune system, retards mental and motor development and decreases the work performance of up to 2 billion people worldwide (ACC/SCN, 2004) This can however to a large extent be prevented and controlled cost-effectively by fortification of a regularly consumed food vehicle with a highly bioavailable iron compound, which does not adversely affect the technologic and hedonic characteristics of the vehicle (Behrman et al., 2004; Hurrell, 2004) . As one of the first steps in the process of identifying the optimal compound-vehicle combination, human bioavailability studies of isotopically labeled iron compounds are essential.
Bioavailability studies in humans are performed using iron compounds containing either radioisotopes or stable isotopes. Although methods for detecting radioisotopes are very sensitive, thus enabling administration of low doses, reluctance to use them exists, because high doses may be harmful. The widespread availability of stable isotopes, their lowered cost and improved sensitivity of detection methods have made them the isotopes of choice for bioavailability studies in humans, especially in children. Stable iron isotopes ( 57 Fe and 58 Fe) are purchased commercially in the form of iron metal and have to be converted to the various salts or chelates via chemical synthesis methods before use. Sodium iron (III) ethylenediaminetetraacetic acid (EDTA) is not only one of the most bioavailable iron compounds available, but unlike other compounds in its slipstream, is less sensitive to iron absorption inhibiting factors and increases the bioavailability of ingested dietary iron from other foods (Hurrell, 2004) . Despite major interest in its potential use in food fortification programs, and thus the need to study its bioavailability, synthesis methods of stable isotope-labeled sodium iron (III) EDTA are incomplete, incorrect or totally lacking. As iron deficiency and its anemia is most prevalent in developing countries, owing to diets deficient in highly bioavailable iron and high in inhibitors that limit iron bioavailability, many bioavailability studies are performed under technologically limited conditions on a tight budget. With this in mind, we optimized the synthesis of sodium iron (III) EDTA from a block of isotopically enriched iron metal. , 1999) . There are two generally accepted methods for performing this. Firstly, chlorine gas may be bubbled through the solution, and secondly, hydrogen peroxide liberating chlorine gas from HCl may be used. As there is already HCl in this reaction mixture, the latter method was chosen by us for chlorine gas generation. Seven millimolar hydrogen peroxide (TraceSelectUltra -Sigma) was added and the chlorine gas generation was allowed to take place to completion with slight heating. EDTA disodium salt dihydrate (Na 2 EDTA Á 2H 2 O) (BiochemikaUltra -Sigma) was added to the FeCl 3 solution in at a molar ratio of 1:1 (Fe:EDTA). The FeCl 3 solution is, however, too acidic for direct addition of the Na 2 EDTA Á 2H 2 O. Direct addition of this salt to the FeCl 3 solution at these low pH values would result in the precipitation of EDTA. The Na 2 EDTA Á 2H 2 O is consequently pre-dissolved in 2 ml of a 5 mM NaOH (SigmaUltra -Sigma), prepared with doubledeionized sterile water. This solution is added dropwise to the FeCl 3 while swirling continuously. A brown coloration forms as the NaOH-Na 2 EDTA solution makes contact with the FeCl 3 solution in the flask, and then quickly disappears with mixing. This brown residue is owing to the formation of an iron (III) hydroxo complex, which forms in the immediate contact area of the NaOH, owing to the higher pH of this solution. An excessively high final pH value (pH 46) of the final reaction mixture would result in a precipitation of iron (III) hydroxide, which can be easily rectified by the addition of HCl. The resulting ( 57 Fe or 58 Fe) NaFe(III)EDTA solution was made up to the desired concentration (10 mg Fe/ml) with double-distilled deionized sterile water. Should a powder be required for use in the bioavailability study to follow, drying the product solution under a nitrogen stream may be carried out without any product degradation or loss in product purity.
Using electrospray ionization mass spectrometry and capillary zone electrophoresis, two independent laboratories confirmed the purity of the product at 499.0%, with no impurities detected (detection limit 0.05 wt%). Additionally, the isotope-labeled sodium iron (III) EDTA produced in this synthesis complies with the Joint FAO/WHO Expert Committee of Food Additives specifications for food fortification.
As this synthesis only requires basic and inexpensive general laboratory equipment and reagents, it can be reproduced cheaply, anywhere in the world. Furthermore, the simplicity of this method allows for the many clinical research groups, currently doing such studies, to perform their own syntheses. We additionally anticipate that more uniformity in the synthesis of sodium iron (III) EDTA will reduce the variation observed between such bioavailability studies (Thuy et al., 2003; Walter et al., 2003) . This would enable more unambiguous conclusions to be derived from such studies, which would greatly benefit the decisionmaking process facing public-private partnerships in many countries for the identification of the most suitable iron compound-vehicle combination. Evidence-based decisions are determined by four factors: the bioavailability of isotopically labeled compounds in different food matrices in humans; large-scale efficacy studies of the most suitable compounds in the preferred food vehicle; even larger-scale effectiveness studies of the preferred compound-vehicle combination; and the absence of adverse technologic and hedonic affects, such as changes in stability, color and taste. There is mounting evidence that sodium iron (III) EDTA behaves favorably in all four of the above-mentioned factors (Viteri et al., 1995; Davidsson et al., 2002; Thuy et al., 2003; Walter et al., 2003; Hurrell, 2004; Chen et al., 2005) . Therefore, as proof-of-principle studies, studies of the bioavailability of isotopically labeled sodium iron (III) EDTA, under many circumstances, and in many populations are required. Such research currently has a high priority as, without people having to change their dietary habits, effective food fortification programs can significantly reduce global iron deficiency and its anemia, affecting so many people today. Furthermore, by provoking humanitarian health benefits and an increased work performance, such an intervention would ultimately propel gross domestic product, especially in developing countries most affected by this deficiency (Behrman et al., 2004 (FAO, 2004) was derived from a revision of compiled data performed by Schofield (1985) from studies mainly conducted in the first half of the 20th century in samples that were not representative of any specific population. Initially in the tropics (geographic region of the Earth centered on the equator and limited by the Tropic of Cancer in the north and
